Trion Pharma Limited - Accounts to registrar (filleted) - small 23.2.5

Trion Pharma Limited - Accounts to registrar (filleted) - small 23.2.5

TRION PHARMA LIMITED - Company Information

Print Friendly Version

IRIS Accounts Production v23.3.0.418 09293856 director 1.11.21 31.10.22 31.10.22 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure092938562021-10-31092938562022-10-31092938562021-11-012022-10-31092938562020-10-31092938562020-11-012021-10-31092938562021-10-3109293856ns16:EnglandWales2021-11-012022-10-3109293856ns15:PoundSterling2021-11-012022-10-3109293856ns11:Director12021-11-012022-10-3109293856ns11:PrivateLimitedCompanyLtd2021-11-012022-10-3109293856ns11:SmallEntities2021-11-012022-10-3109293856ns11:AuditExempt-NoAccountantsReport2021-11-012022-10-3109293856ns11:SmallCompaniesRegimeForDirectorsReport2021-11-012022-10-3109293856ns11:SmallCompaniesRegimeForAccounts2021-11-012022-10-3109293856ns11:FullAccounts2021-11-012022-10-3109293856ns11:OrdinaryShareClass12021-11-012022-10-3109293856ns11:RegisteredOffice2021-11-012022-10-3109293856ns6:CurrentFinancialInstruments2022-10-3109293856ns6:CurrentFinancialInstruments2021-10-3109293856ns6:ShareCapital2022-10-3109293856ns6:ShareCapital2021-10-3109293856ns6:RetainedEarningsAccumulatedLosses2022-10-3109293856ns6:RetainedEarningsAccumulatedLosses2021-10-3109293856ns6:PlantMachinery2021-11-012022-10-3109293856ns6:LandBuildings2021-10-3109293856ns6:PlantMachinery2021-10-3109293856ns6:LandBuildings2021-11-012022-10-3109293856ns6:LandBuildings2022-10-3109293856ns6:PlantMachinery2022-10-3109293856ns6:LandBuildings2021-10-3109293856ns6:PlantMachinery2021-10-3109293856ns6:AdditionsToInvestments2022-10-3109293856ns6:CostValuation2022-10-3109293856ns6:WithinOneYearns6:CurrentFinancialInstruments2022-10-3109293856ns6:WithinOneYearns6:CurrentFinancialInstruments2021-10-3109293856ns11:OrdinaryShareClass12022-10-31
REGISTERED NUMBER: 09293856 (England and Wales)


Financial Statements for the Year Ended 31 October 2022

for

Trion Pharma Limited
Trion Pharma Limited (Registered number: 09293856)






Contents of the Financial Statements
for the Year Ended 31 October 2022




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Trion Pharma Limited

Company Information
for the Year Ended 31 October 2022







DIRECTOR: Mr Vipulkumar Patel





REGISTERED OFFICE: Bridge House
9-13 Holbrook Lane
Covnetry
West Midlands
CV6 4AD





REGISTERED NUMBER: 09293856 (England and Wales)





ACCOUNTANTS: Sterling Accounting Services Limited
Bridge House
9-13 Holbrook Lane
Coventry
CV6 4AD
Page 1
Trion Pharma Limited (Registered number: 09293856)

Statement of Financial Position
31 October 2022

31.10.22 31.10.21
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 321,760 163,508
Investments 5 100 -
321,860 163,508

CURRENT ASSETS
Stocks 251,180 -
Debtors 6 2,882,163 2,109,489
Cash at bank and in hand 6,634,889 3,013,413
9,768,232 5,122,902
CREDITORS
Amounts falling due within one year 7 6,033,917 3,757,225
NET CURRENT ASSETS 3,734,315 1,365,677
TOTAL ASSETS LESS CURRENT
LIABILITIES
4,056,175
1,529,185

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 4,056,075 1,529,085
SHAREHOLDERS' FUNDS 4,056,175 1,529,185

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The notes form part of these financial statements

Page 2 continued...
Trion Pharma Limited (Registered number: 09293856)

Statement of Financial Position - continued
31 October 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 October 2023 and were signed by:





Mr Vipulkumar Patel - Director


The notes form part of these financial statements

Page 3
Trion Pharma Limited (Registered number: 09293856)

Notes to the Financial Statements
for the Year Ended 31 October 2022

1. STATUTORY INFORMATION

Trion Pharma Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2021 - 10 ) .

Page 4 continued...
Trion Pharma Limited (Registered number: 09293856)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 November 2021 - 211,516 211,516
Additions 15,326 219,535 234,861
At 31 October 2022 15,326 431,051 446,377
DEPRECIATION
At 1 November 2021 - 48,008 48,008
Charge for year - 76,609 76,609
At 31 October 2022 - 124,617 124,617
NET BOOK VALUE
At 31 October 2022 15,326 306,434 321,760
At 31 October 2021 - 163,508 163,508

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
Additions 100
At 31 October 2022 100
NET BOOK VALUE
At 31 October 2022 100

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.22 31.10.21
£    £   
Trade debtors 666,778 877,069
Other debtors 2,215,385 1,232,420
2,882,163 2,109,489

Page 5 continued...
Trion Pharma Limited (Registered number: 09293856)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.22 31.10.21
£    £   
Trade creditors 4,691,152 3,027,249
Taxation and social security 1,059,917 596,831
Other creditors 282,848 133,145
6,033,917 3,757,225

8. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 31.10.22 31.10.21
value: £    £   
100 Share capital 1 £1 100 100

Page 6